These pages make it easy to explore all of our resources by topic.
Note that we are currently updating this section of our website and will be adding more topics pages over the coming months.
- A
- B
- C
- cannabis
- characteristics of frequent and high-risk cannabis users
- cannabis, drug profile
- markets, new developments in Europe's cannabis market
- models for the legal supply of cannabis — recent developments
- policy, status of and recent changes
- possession of cannabis for personal use, legal status
- resin market: changes in Europe
- cocaine
- consumption rooms — see 'drug consumption rooms'
- control status by drug — see 'drug profiles'
- cannabis
- D
- darknet
- deaths and overdose
- drug profiles — scientific descriptions of drugs including chemistry, pharmacology, synthesis, precursors and control status
- amphetamine drug profile
- barbiturates drug profile
- benzodiazepines drug profile
- BZP and other piperazines drug profile
- cannabis drug profile
- cocaine and crack drug profile
- fentanyl drug profile
- hallucinogenic mushrooms drug profile
- heroin drug profile
- khat drug profile
- LSD drug profile
- MDMA ('ecstasy') drug profile
- methamphetamine drug profile
- salvia divinorum drug profile
- synthetic cannabinoids and 'Spice' drug profile
- synthetic cathinones drug profile
- synthetic cocaine derivatives drug profile
- volatile substances drug profile
- driving and drugs
- drug consumption rooms, an overview of provision and evidence
- E
- ecstasy —see 'MDMA'
- European Drug Report — annual overview of trends, data and analysis of the drug situation in Europe
- European Legal Database on Drugs (ELDD)
- European Union (EU)
- events (see meetings and events)
- F
- G
- H
- hallucinogenic mushrooms
- harm reduction — see 'health and social responses'
- health and social responses
- cocaine dependence, treatment for — reviewing current evidence
- drug consumption rooms, an overview of provision and evidence
- harm reduction
- Health and social responses guide
- hepatitis C treatment for injecting drug users
- Internet-based drug treatment
- legal framework of opioid substitution treatment (OST)
- methamphetamine users, health and social responses for
- monitoring drug treatment (under 'Our activities' ⇝)
- monitoring harm reduction (under 'Our activities' ⇝)
- monitoring health and social responses (under 'Our activities' ⇝)
- monitoring social reintegration (under 'Our activities' ⇝)
- opioid substitution treatment: strategies to prevent the diversion of
- preventing overdose deaths in Europe
- Prevention topics page
- hepatitis — see 'infectious diseases'
- heroin — see 'opioids'
- I
- J K L
- key epidemiological indicators (under 'Our activities' ⇝>)
- khat, drug profile
- laws and legal aspects
- classification of controlled drugs
- cannabis, personal possession
- consumption, illegal consumption of drugs and the law
- controlled deliveries, legal aspects
- driving, legal approaches
- hallucinogenic mushrooms, legal status of
- medical purposes, supplying illicit drugs for
- needle and syringe programmes (NSP), legal framework of
- new psychoactive substances, legal approaches to controlling
- opioid substitution treatment (OST), legal status of
- penalties, drug law penalties at a glance
- possession, illegal possession of drugs
- precursor offences, penalties for
- prison, treatment alternatives to prosecution or prison
- threshold quantities for possession and supply offences
- workplace drug testing, legal status of
- LSD, drug profile
- M
- MDMA
- meetings and events
- methamphetamine
- N
- O
- opioids
- opioid substitution treatment (OST) — see 'health and social responses'
- overdoses — see 'deaths and overdose'
- Q P R
- Partners (under 'About' ⇝)
- European Parliament partner
- Council of the European Union partner
- European Commission partner
- European Police Office (Europol) partner
- European Centre for Disease Control (ECDC) partner
- European Medicines Agency (EMA) partner
- Eurojust partner
- European Police College (CEPOL) partner
- Reitox network partner
- United Nations Office on Drug and Crime (UNODC) partner
- Joint United Nations Programme on HIV/AIDS (UNAIDS) partner
- World Health Organisation (WHO) partner
- Pompidou Group partner
- Maritime Analysis and Operation Centre–Narcotics (MAOC-N) partner
- The International Criminal Police Organization (Interpol) partner
- World Customs Organisation (WCO) partner
- Inter-American Drug Abuse Control Commission (CICAD)
- European School Survey Project on Alcohol and Other Drugs (ESPAD) partner
- Candidate and potential candidate countries partners
- Neighbouring countries and Russia partners
- penalties, drug law penalties at a glance
- Perspectives on drugs series — topical analyses providing deeper insights into a selection of important issues
- benzodiazepine mis-use among high-risk opioid users in Europe
- cannabis: characteristics of frequent cannabis users
- cannabis: legal supply
- cannabis market in Europep
- cannabis resin market: changes in Europe
- cocaine: emergencies related to cocaine-use
- cocaine: trafficking to Europe
- comorbidity of drug use and mental health disorders
- drug consumption rooms, an overview of provision and evidence
- EU Drugs Strategy 2013–20
- hepatitis C treatment for injecting drug users
- heroin: trends in heroin use
- injection of synthetic cathinones
- internet-based drug treatment
- mass media campaigns — do they work?
- new psychoactive substances: health responses to
- new psychoactive substances: legal approaches to controlling
- opioid substitution treatment: strategies to prevent the diversion of
- opioid trafficking routes from Asia to Europe
- overdose deaths: preventing overdose deaths
- psychosocial interventions
- responses for methamphetamine users
- synthetic cannabinoids in Europe
- synthetic drug production in Europe
- treatment for cocaine dependence
- wastewater analysis and drugs — a European multi-city study
- policy
- precursors
- prevention
- prison
- production — see 'supply and production'
- public expenditure
- psychosocial interventions
- research, drug-related (under 'Our activities' ⇝)
- responses — see 'health and social responses'
- Partners (under 'About' ⇝)
- S
- salvia divinorum, drug profile
- scientific paper award (under 'Our activities' ⇝)
- social reintegration — monitoring (under 'Our activities' ⇝)
- statistics and data (under 'Data' ⇝)
- strategies and action plans
- supply, markets and production
- synthetic cannabinoids
- synthetic cathinones
- T
- trafficking
- treatment
- U V W
- X Y Z
- young people
These pages allow you to easily see all of the content we have on a particular topic.
We will be adding more of these pages over the coming months.
These designed-for-the-web analyses incorporate video and interactive features, providing deeper insights into a selection of important issues.
- benzodiazepine mis-use among high-risk opioid users in Europe
- cannabis: characteristics of frequent cannabis users
- cannabis: legal supply
- cannabis market in Europe
- cannabis resin market: changes in Europe
- cocaine: emergencies related to cocaine-use
- cocaine: trafficking to Europe
- comorbidity of drug use and mental health disorders
- drug consumption rooms, an overview of provision and evidence
- EU Drugs Strategy 2013–20
- hepatitis C treatment for injecting drug users
- heroin: trends in heroin use
- injection of synthetic cathinones
- internet-based drug treatment
- mass media campaigns — do they work?
- new psychoactive substances: health responses to
- new psychoactive substances: legal approaches to controlling
- opioid substitution treatment: strategies to prevent the diversion of
- opioid trafficking routes from Asia to Europe
- overdose deaths: preventing overdose deaths
- psychosocial interventions
- responses for methamphetamine users
- synthetic cannabinoids in Europe
- synthetic drug production in Europe
- treatment for cocaine dependence
- wastewater analysis and drugs — a European multi-city study
Use the links below to discover other drug-related content on our website. For a full listing of drug-related topics covered on the website, please use the A-Z index tab.
- All activities — the EMCDDA is active in many areas including epidemiology, responses, law, policy and supply (under 'Our activities' ⇝)
- Drug profiles — scientific descriptions of drugs covering chemistry, pharmacology, synthesis, precursors, control status and more
- European Drug Report — annual overview of trends, data and analysis of the drug situation in Europe
- Key indicators — the main epidemiological indicators used to monitor the European drug situation (under 'Our activities' ⇝)
- Legal topic overviews — a thematic-based examination of some of the legal aspects of drugs and drug use
- New psychoactive substances — information on our activity in the area of new drugs is presented in 'Action on new drugs' (under 'Our activities' ⇝)
- Partners — information on our partnerships with other organisations (under 'About' ⇝)
- Perspectives on drugs — topical analyses providing deeper insights into a broad selection of important issues